Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000706

Director sold 69,859 shares at an average $16.84 ($1,176,710)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-07-13 Sale : show line 1 in the form −33,629 $16.87 $567,321 2,392,806 I
2017-07-14 Sale : show line 2 in the form −36,230 $16.82 $609,389 2,356,576 I
Open-market sales · 69,859 sh · avg $16.84 · $1,176,710
Loading xslF345X03/vonemster_fm4july132017.xml…